Georgia Arrhythmia Consultants and Research Institute — Macon, Georgia

Georgia Arrhythmia Consultants and Research Institute is a clinical research site located in Macon, Georgia, United States 31201.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Georgia Arrhythmia Consultants and Research Institute has participated in 5 clinical trials.

Therapeutic areas: Heart Failure, Iron-deficiency, Atrial Fibrillation.

Sponsors: American Regent, Inc., American Heart Association, Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Macon

Browse all research sites in Georgia · View every site in Macon

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgia Arrhythmia Consultants and Research Institute?

Georgia Arrhythmia Consultants and Research Institute has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgia Arrhythmia Consultants and Research Institute conducted?

Georgia Arrhythmia Consultants and Research Institute has 5 clinical trials on record. Their work covers Heart Failure, Iron-deficiency, Atrial Fibrillation.

Is Georgia Arrhythmia Consultants and Research Institute accredited by Crixeo Clinical Trials?

Georgia Arrhythmia Consultants and Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgia Arrhythmia Consultants and Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.